BBIO

SEC source: 0000899243-20-018288 · doc4.xml · nonDerivative · entry 2

Turtle Cameron · CIK 0001758363 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,823

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-20-018288 · doc4.xml · nonDerivative · entry 1

Turtle Cameron · CIK 0001758363 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,823

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-20-017667 · doc4.xml · derivative · entry 1

Scott Randal W · CIK 0001337801 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,223

Underlying: Common Stock · 101,223 shares

Expires 2030-06-22

F1 · derivative.exercise_date: The shares subject to this option vest and become exercisable in three annual installments after June 23, 2020, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

SEC source: 0000899243-20-017666 · doc4.xml · derivative · entry 1

SAUNDERS BRENT L · CIK 0001268854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,223

Underlying: Common Stock · 101,223 shares

Expires 2030-06-22

F1 · derivative.exercise_date: The shares subject to this option vest and become exercisable in three annual installments after June 23, 2020, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

SEC source: 0000899243-20-017663 · doc4.xml · derivative · entry 1

Lo Andrew · CIK 0001679076 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,223

Underlying: Common Stock · 101,223 shares

Expires 2030-06-22

F1 · derivative.exercise_date: The shares subject to this option vest and become exercisable in three annual installments after June 23, 2020, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

SEC source: 0000899243-20-015951 · doc4.xml · nonDerivative · entry 1

STEPHENSON BRIAN C · CIK 0001780030 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,116

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019.

F2 · price: Represents the weighted average sale price of the shares sold from $30.00 to $30.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000899243-20-015957 · doc4.xml · nonDerivative · entry 2

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,293

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019.

SEC source: 0000899243-20-015957 · doc4.xml · nonDerivative · entry 1

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,393

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019.

SEC source: 0000899243-20-015953 · doc4.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,308,842

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019.

F2 · price: Represents the weighted average sale price of the shares sold from $30.00 to $30.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0000899243-20-015540 · doc4.xml · derivative · entry 3

STEPHENSON BRIAN C · CIK 0001780030 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,356

Underlying: Common Stock · 27,356 shares

Expires not disclosed

F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date.

F5 · derivative.expiration_date: The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date.

SEC source: 0000899243-20-015540 · doc4.xml · derivative · entry 2

STEPHENSON BRIAN C · CIK 0001780030 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,850

Underlying: Common Stock · 196,850 shares

Expires 2030-06-02

F3 · derivative.exercise_date: The Option will vest over approximately four years. 1/48th of the shares of Common Stock underlying the Option will vest on a monthly basis after June 3, 2020 (the "Vesting Commencement Date"), such that all of the shares underlying the Option will be vested on the date four (4) years after the Vesting Commencement Date, subject to the Reporting Person's continued Service Relationship (as defined in the Plan) with the Issuer or any of its subsidiaries through the applicable vesting date.

SEC source: 0000899243-20-015540 · doc4.xml · nonDerivative · entry 1

STEPHENSON BRIAN C · CIK 0001780030 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,116

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019.

F2 · price: Represents the weighted average sale price of the shares sold from $30.00 to $30.13 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000899243-20-015541 · doc4.xml · derivative · entry 2

YAU YI CHING · CIK 0001790097 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,383

Underlying: Common Stock · 6,383 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date.

F3 · derivative.expiration_date: The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date.

SEC source: 0000899243-20-015541 · doc4.xml · derivative · entry 1

YAU YI CHING · CIK 0001790097 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,931

Underlying: Common Stock · 45,931 shares

Expires 2030-06-02

F1 · derivative.exercise_date: The Option will vest over approximately four years. 1/48th of the shares of Common Stock underlying the Option will vest on a monthly basis after June 3, 2020 (the "Vesting Commencement Date"), such that all of the shares underlying the Option will be vested on the date four (4) years after the Vesting Commencement Date, subject to the Reporting Person's continued Service Relationship (as defined in the Plan) with the Issuer or any of its subsidiaries through the applicable vesting date.

SEC source: 0000899243-20-015537 · doc4.xml · derivative · entry 2

Stolz Brian M. · CIK 0001524803 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,532

Underlying: Common Stock · 25,532 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date.

F3 · derivative.expiration_date: The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date.

SEC source: 0000899243-20-015537 · doc4.xml · derivative · entry 1

Stolz Brian M. · CIK 0001524803 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,727

Underlying: Common Stock · 183,727 shares

Expires 2030-06-02

F1 · derivative.exercise_date: The Option will vest over approximately four years. 1/48th of the shares of Common Stock underlying the Option will vest on a monthly basis after June 3, 2020 (the "Vesting Commencement Date"), such that all of the shares underlying the Option will be vested on the date four (4) years after the Vesting Commencement Date, subject to the Reporting Person's continued Service Relationship (as defined in the Plan) with the Issuer or any of its subsidiaries through the applicable vesting date.

SEC source: 0000899243-20-015534 · doc4.xml · derivative · entry 5

Kumar Neil · CIK 0001742485 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,069

Underlying: Common Stock · 82,069 shares

Expires not disclosed

F6 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F7 · derivative.exercise_date: The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date.

F7 · derivative.expiration_date: The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date.

SEC source: 0000899243-20-015534 · doc4.xml · derivative · entry 4

Kumar Neil · CIK 0001742485 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 590,551

Underlying: Common Stock · 590,551 shares

Expires 2030-06-02

F5 · derivative.exercise_date: The Option will vest over approximately four years. 1/48th of the shares of Common Stock underlying the Option will vest on a monthly basis after June 3, 2020 (the "Vesting Commencement Date"), such that all of the shares underlying the Option will be vested on the date four (4) years after the Vesting Commencement Date, subject to the Reporting Person's continued Service Relationship (as defined in the Plan) with the Issuer or any of its subsidiaries through the applicable vesting date.

SEC source: 0000899243-20-015534 · doc4.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,319,442

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019.

F2 · price: Represents the weighted average sale price of the shares sold from $30.00 to $30.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0000899243-20-032503 · doc4.xml · nonDerivative · entry 1

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,399

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019.

F2 · price: Represents the weighted average sale price of the shares sold from $30.00 to $30.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000899243-20-015308 · doc4.xml · derivative · entry 1

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,422

Underlying: Common Stock · 112,422 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.

SEC source: 0000899243-20-015306 · doc4.xml · derivative · entry 1

HOMCY CHARLES J · CIK 0001192591 · Director · Chairman of Pharmaceuticals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,422

Underlying: Common Stock · 112,422 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.

SEC source: 0000899243-20-015304 · doc4.xml · derivative · entry 1

MOMTAZEE JAMES C · CIK 0001209181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,422

Underlying: Common Stock · 112,422 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.

SEC source: 0000899243-20-015302 · doc4.xml · derivative · entry 1

Satvat Ali J. · CIK 0001621788 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,422

Underlying: Common Stock · 112,422 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.

SEC source: 0000899243-20-015301 · doc4.xml · derivative · entry 1

SCHELLER RICHARD H · CIK 0001214133 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,422

Underlying: Common Stock · 112,422 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.

SEC source: 0000899243-20-015297 · doc4.xml · derivative · entry 1

AGUIAR ERIC · CIK 0001262325 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,422

Underlying: Common Stock · 112,422 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.

SEC source: 0000899243-20-015043 · doc4.xml · nonDerivative · entry 2

STEPHENSON BRIAN C · CIK 0001780030 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,716

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019.

F3 · price: Represents the weighted average sale price of the shares sold from $29.66 to $29.875 per share.

SEC source: 0000899243-20-015043 · doc4.xml · nonDerivative · entry 1

STEPHENSON BRIAN C · CIK 0001780030 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,616

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019.

F2 · price: Represents the weighted average sale price of the shares sold from $28.66 to $29.64 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.

SEC source: 0000899243-20-015047 · doc4.xml · derivative · entry 1

Sinha Uma · CIK 0001742587 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020. 6.25% of the RSUs will vest on August 16, 2020 and an additional 6.25% will vest in quarterly installments thereafter, subject to continued service with the Issuer or any of its subsidiaries through each applicable vesting date.

F2 · derivative.expiration_date: The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020. 6.25% of the RSUs will vest on August 16, 2020 and an additional 6.25% will vest in quarterly installments thereafter, subject to continued service with the Issuer or any of its subsidiaries through each applicable vesting date.

SEC source: 0000899243-20-015042 · doc4.xml · nonDerivative · entry 2

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,683

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019.

F3 · price: Represents the weighted average sale price of the shares sold from $29.68 to $29.86 per share.

SEC source: 0000899243-20-015042 · doc4.xml · nonDerivative · entry 1

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,183

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019.

F2 · price: Represents the weighted average sale price of the shares sold from $28.65 to $29.64 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.

SEC source: 0000899243-20-015045 · doc4.xml · nonDerivative · entry 2

Kumar Neil · CIK 0001742485 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,325,372

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019.

F4 · price: Represents the weighted average sale price of the shares sold from $29.60 to $29.965 per share.

F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0000899243-20-015045 · doc4.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,334,081

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019.

F2 · price: Represents the weighted average sale price of the shares sold from $28.60 to $29.59 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4.

F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0001140361-20-012852 · form4.xml · nonDerivative · entry 1

KKR Genetic Disorder L.P. · CIK 0001780408 · 10% owner

KKR Genetic Disorder GP LLC · CIK 0001780428 · 10% owner

KKR Group Partnership L.P. · CIK 0001472698 · 10% owner

KKR Group Holdings Corp. · CIK 0001743754 · 10% owner

KKR & Co. Inc. · CIK 0001404912 · 10% owner

KKR Management LLP · CIK 0001472694 · 10% owner

KRAVIS HENRY R · CIK 0001081714 · 10% owner

ROBERTS GEORGE R · CIK 0001081715 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 34,510,971

F1 · ownership.nature: The securities of the Issuer are held by KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC, as the general partner of KKR Genetic Disorder L.P., KKR Group Partnership L.P., as the sole member of KKR Genetic Disorder GP LLC, KKR Group Holdings Corp., as the general partner of KKR Group Partnership L.P., KKR & Co. Inc., as the sole shareholder of KKR Group Holdings Corp., KKR Management LLP, as the Series I preferred stockholder of KKR & Co. Inc., and Messrs. Henry R. Kravis and George R. Roberts, as the founding partners of KKR Management LLP, may be deemed to be the beneficial owners having shared voting and investment power with respect to the shares described above. Each of Messrs. Kravis and Roberts disclaims beneficial ownership of the shares held by KKR Genetic Disorder L.P.

F2 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.

SEC source: 0000899243-20-014325 · doc4.xml · derivative · entry 2

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,365 shares

Expires 2029-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-20-014325 · doc4.xml · nonDerivative · entry 1

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,268

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-20-013850 · doc4.xml · derivative · entry 11

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,365

Underlying: Common Stock · 18,365 shares

Expires 2029-12-17

F4 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

SEC source: 0000899243-20-013850 · doc4.xml · derivative · entry 10

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,271

Underlying: Common Stock · 19,271 shares

Expires 2028-06-24

F4 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

F8 · derivative.exercise_date: 10,840 shares subject to the stock option were vested as of the date of acquisition, 402 shares shall vest on May 23, 2020, and 8,029 shares shall vest in monthly installments over the next 20 months thereafter, in each case so long as the Reporting Person continues to have a service relationship with the Issuer or a Subsidiary on each such date.

SEC source: 0000899243-20-013850 · doc4.xml · derivative · entry 9

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,027

Underlying: Common Stock · 45,027 shares

Expires 2029-09-24

F4 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

SEC source: 0000899243-20-013850 · doc4.xml · derivative · entry 8

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,932

Underlying: Common Stock · 13,932 shares

Expires 2029-09-24

F4 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

SEC source: 0000899243-20-013850 · doc4.xml · derivative · entry 7

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,351

Underlying: Common Stock · 3,351 shares

Expires 2029-06-10

F4 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

F7 · derivative.exercise_date: 2,030 shares shall vest and become exercisable on June 11, 2020, and 1,321 shares shall vest and become exercisable in monthly installments over the next 8 months thereafter, in each case so long as the Reporting Person continues to have a service relationship with the Issuer or a Subsidiary on each such date.

SEC source: 0000899243-20-013850 · doc4.xml · derivative · entry 6

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,778

Underlying: Common Stock · 7,778 shares

Expires 2029-05-28

F4 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

F6 · derivative.exercise_date: 5,654 shares subject to the stock option were vested as of the date of acquisition, 514 shares shall vest on May 29, 2020, and 1,610 shares shall vest in monthly installments over the next 4 months thereafter, in each case so long as the Reporting Person continues to have a service relationship with the Issuer or a Subsidiary on each such date.

SEC source: 0000899243-20-013850 · doc4.xml · derivative · entry 5

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,487

Underlying: Common Stock · 39,487 shares

Expires 2028-08-26

F4 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

F5 · derivative.exercise_date: 34,901 shares subject to the stock option were vested as of the date of acquisition, 1,246 shares shall vest May 22, 2020, and 3,340 shares shall vest in monthly installments over the next 3 months thereafter, in each case so long as the Reporting Person continues to have a service relationship with the Issuer or a Subsidiary on each such date.

SEC source: 0000899243-20-013850 · doc4.xml · derivative · entry 4

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,019

Underlying: Common Stock · 1,019 shares

Expires 2028-05-07

F4 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

SEC source: 0000899243-20-013850 · doc4.xml · derivative · entry 3

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,335

Underlying: Common Stock · 7,335 shares

Expires 2027-11-13

F4 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

SEC source: 0000899243-20-013850 · doc4.xml · derivative · entry 2

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,000

Underlying: Common Stock · 205,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date.

F3 · derivative.exercise_date: 6.25% of the units will vest on August 16, 2020 and an additional 6.25% of the units will vest in quarterly installments on the 16th day of February, May, August and November until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its Subsidiaries through each applicable vesting date.

F2 · derivative.expiration_date: Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date.

SEC source: 0000899243-20-013850 · doc4.xml · nonDerivative · entry 1

HENDERSON MICHAEL THOMAS · CIK 0001779990 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,903

F1 · kind: The shares were acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in privately-held subsidiaries of the Issuer (each, a "Subsidiary" and collectively, the "Subsidiaries").

SEC source: 0000899243-20-013844 · doc4.xml · derivative · entry 3

Turtle Cameron · CIK 0001758363 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,766

Underlying: Common Stock · 49,766 shares

Expires 2029-07-14

F1 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in privately-held subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

SEC source: 0000899243-20-013844 · doc4.xml · derivative · entry 2

Turtle Cameron · CIK 0001758363 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,042

Underlying: Common Stock · 74,042 shares

Expires 2029-05-23

F1 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in privately-held subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.

SEC source: 0000899243-20-013844 · doc4.xml · derivative · entry 1

Turtle Cameron · CIK 0001758363 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,082

Underlying: Common Stock · 1,082 shares

Expires 2027-08-23

F1 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in privately-held subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio.